Huadong Medicine Co., Ltd - Laporan Laba Rugi (TTM)

Huadong Medicine Co., Ltd
CN ˙ SZSE ˙ CNE0000011S1
CN¥ 43.63 ↑1.08 (2.54%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Huadong Medicine Co., Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 33,319 33,683 33,982 34,202 34,110 34,563 34,599 35,582 36,494 37,715 38,897 39,902 40,251 40,624 40,920 41,204 41,707 41,906 42,231 42,616
Change (%) 1.09 0.89 0.65 -0.27 1.33 0.10 2.84 2.56 3.34 3.13 2.58 0.87 0.93 0.73 0.69 1.22 0.48 0.78 0.91
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 22,130 22,555 23,239 23,460 23,635 23,969 24,078 24,626 25,155 25,686 26,562 27,364 27,391 27,468 27,754 27,657 27,989 28,006 28,137 28,224
Change (%) 1.92 3.03 0.95 0.75 1.41 0.46 2.27 2.15 2.11 3.41 3.02 0.10 0.28 1.04 -0.35 1.20 0.06 0.46 0.31
% of Revenue 66.42 66.96 68.39 68.59 69.29 69.35 69.59 69.21 68.93 68.11 68.29 68.58 68.05 67.62 67.82 67.12 67.11 66.83 66.63 66.23
Gross Operating Profit 11,189 11,128 10,742 10,741 10,474 10,595 10,521 10,956 11,339 12,028 12,334 12,538 12,860 13,156 13,166 13,546 13,718 13,899 14,094 14,392
Change (%) -0.54 -3.47 -0.01 -2.49 1.15 -0.70 4.14 3.50 6.08 2.55 1.65 2.56 2.30 0.08 2.89 1.27 1.32 1.40 2.11
% of Revenue 33.58 33.04 31.61 31.41 30.71 30.65 30.41 30.79 31.07 31.89 31.71 31.42 31.95 32.38 32.18 32.88 32.89 33.17 33.37 33.77
SG&A 6,891 6,992 6,810 6,898 6,675 6,633 6,443 6,758 7,104 7,652 7,889 7,817 7,928 8,091 8,028 8,297 8,246 7,918 7,835 7,909
Change (%) 1.47 -2.60 1.29 -3.23 -0.63 -2.86 4.89 5.11 7.72 3.09 -0.91 1.42 2.06 -0.78 3.35 -0.62 -3.97 -1.05 0.95
% of Revenue 20.68 20.76 20.04 20.17 19.57 19.19 18.62 18.99 19.46 20.29 20.28 19.59 19.70 19.92 19.62 20.14 19.77 18.90 18.55 18.56
R&D 1,051 927 883 885 964 980 1,079 1,109 1,040 1,016 962 1,008 1,069 1,271 1,287 1,356 1,379 1,426 1,659 1,782
Change (%) -11.79 -4.68 0.14 9.02 1.58 10.13 2.77 -6.18 -2.33 -5.29 4.73 6.03 18.92 1.27 5.33 1.71 3.41 16.40 7.40
% of Revenue 3.15 2.75 2.60 2.59 2.83 2.83 3.12 3.12 2.85 2.69 2.47 2.53 2.65 3.13 3.15 3.29 3.31 3.40 3.93 4.18
OpEx 30,234 30,658 31,052 31,370 31,408 31,757 31,844 32,732 33,531 34,560 35,618 36,451 36,648 37,034 37,252 37,459 37,793 37,565 37,874 38,214
Change (%) 1.40 1.28 1.02 0.12 1.11 0.27 2.79 2.44 3.07 3.06 2.34 0.54 1.05 0.59 0.56 0.89 -0.60 0.82 0.90
% of Revenue 90.74 91.02 91.38 91.72 92.08 91.88 92.04 91.99 91.88 91.64 91.57 91.35 91.05 91.16 91.04 90.91 90.62 89.64 89.68 89.67
Operating Income 3,085 3,025 2,930 2,832 2,701 2,806 2,755 2,850 2,964 3,155 3,279 3,451 3,603 3,590 3,668 3,745 3,913 4,341 4,356 4,402
Change (%) -1.95 -3.15 -3.34 -4.61 3.89 -1.82 3.45 3.98 6.44 3.93 5.26 4.40 -0.36 2.18 2.08 4.51 10.92 0.35 1.05
% of Revenue 9.26 8.98 8.62 8.28 7.92 8.12 7.96 8.01 8.12 8.36 8.43 8.65 8.95 8.84 8.96 9.09 9.38 10.36 10.32 10.33
Interest Expense -66 -69 -64 -59 -69 -68 -68 -77 -64 -120 -134 -128 -149 -115 -103 -115 -117 -97 -100 -96
Change (%) 3.48 -7.16 -7.75 17.75 -1.07 -0.29 12.33 -16.24 86.84 11.25 -4.19 16.15 -22.69 -9.94 11.34 1.70 -17.26 2.96 -3.71
% of Revenue -0.20 -0.20 -0.19 -0.17 -0.20 -0.20 -0.20 -0.22 -0.18 -0.32 -0.34 -0.32 -0.37 -0.28 -0.25 -0.28 -0.28 -0.23 -0.24 -0.23
Net Income 2,991 2,820 2,431 2,389 2,324 2,302 2,248 2,342 2,388 2,499 2,550 2,592 2,707 2,839 2,946 3,101 3,212 3,512 3,564 3,631
Change (%) -5.74 -13.79 -1.73 -2.73 -0.95 -2.35 4.19 1.96 4.67 2.04 1.66 4.41 4.88 3.77 5.26 3.58 9.34 1.49 1.87
% of Revenue 8.98 8.37 7.15 6.99 6.81 6.66 6.50 6.58 6.54 6.63 6.56 6.50 6.72 6.99 7.20 7.53 7.70 8.38 8.44 8.52

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista